Title Image

Corporate Governance

Board of Directors

Handa upholds integrity principles, emphasizes shareholder rights and principles, and firmly believes that a transparent and efficient board of directors is the cornerstone of corporate sustainability.

The board of directors of All Handa Pharmaceuticals, Inc. is composed of seven directors with professional background and experience. The task of the board of directors is to enhance the Company’s long-term corporate value and improve corporate governance to protect the interests of shareholders and stakeholders. The board also provides strategic management assistance and ensures that the Company adopts and implements planned processes to achieve high standards of integrity, rightness and ethical value.

As a result, three of the seven board members are independent directors and a candidate nomination system has been adopted. The board selects suitable candidates from the list of nominees. An Audit Committee and Remuneration Committee directly subordinate to the board were established. These two functional committees assist the board in the performance of duties in accordance with their authorities.

Board Members

Chairman

Bill Liu Ph.D.

Nationality:USA | Date elected:2019.06.28

● Academic background

Ph.D of Industrial and Physical Pharmacy, Purdue University

● Professional experience

COO and Vice President, Anchen Pharmaceuticals, Inc.
Manager, Business Development and Licensing, Yamanouchi Pharma Technologies
Group Leader, Formulation Development, Impax Pharmaceuticals, Inc.

Director

Maggie Chang Ph.D.

Nationality:USA | Date elected:2019.06.28

● Academic background

Ph.D of Industrial and Physical Pharmacy, Purdue University

● Professional experience

Vice President of Quality Affairs, Anchen Pharmaceuticals, Inc.
Group Leader Analytical Service, Impax Pharmaceuticals, Inc.

Director

Toshiyo Chen

Nationality:ROC | Date elected:2019.06.28

● Academic background

EMBA, National Taiwan University
Bachelor of Pharmacy, Kaohsiung Medical University

● Professional experience

General Manager, TSH Biopharm Corporation Ltd.
Chairman, Pharmira Laboratory Company Ltd.
Sales Director/Senior Director, TTY Biopharm Company Limited.

Director

Sonia Wu

Nationality:ROC | Date elected:2019.06.28

● Academic background

Master of Business Administration, National Taiwan University
Bachelor of Chemical Engineering, National Taiwan University

● Professional experience

Assistant Vice President of CDIB Capital Healthcare Ventures
Assistant Vice President of CDIB Capital Group

Independent Director

Willie Lin Ph.D.

Nationality:ROC | Date elected:2019.06.28

● Academic background

Postdoctoral Researcher of Plant Pathology and Microbology, University of California, Berkeley
Ph.D of Biological Chemistry, Kansas State University

● Professional experience

Chairman/General Manage, Microbio Co., Ltd.
Chairman/General Manage, Fountain Biopharma
General Manage/COO, Fountain Biopharma
Assistant Vice President, China Chemical & Pharmaceutical Co., Ltd.

Independent Director

Will Wang

Nationality:ROC | Date elected:2019.06.28

● Academic background

MBA, Michigan State University
Bachelor of Economics, National Taiwan University

● Professional experience

Independent Director, Cheer Time Enterprise Co., Ltd.
CFO, Tingyi Group
CFO, Ho Tung Chemical Corp.
General Manage, Tingyi Holding Corp.
Senior Vice President, Smith Barney
Senior Vice President/ Representative of Taiwan, Lehman Brothers

Independent Director

Jinn Wu Ph.D.

Nationality:USA | Date elected:2019.06.28

● Academic background

Ph.D of Pharmacy, Ohio State University
Master of Pharmacy, National Taiwan University

● Professional experience

President and Chief Executive Officer, XenoBiotic Laboratories, Inc.
CEO, Nanjing XenoBioticLaboratories, Inc.
Chief Scientific Officer Strategic Advisor, WuXi AppTec
Director, Kinex Pharmaceuticals, Inc.

All members of Handa board must possess the knowledge, skills, literacy and a general skill set necessary to make decisions, conduct risk management and perform management tasks in the pharmaceutical industry, thereby delivering board resolutions that are forward-looking, objective and inclusive. The company also provides directors with a variety of courses that help them enhance professionalism, fulfill their duties of due care as a good administrator and fully perform their function of making business decisions and offering leadership and supervision, thereby strengthening the functions of the board.

Criterion

Name

Operational judgment abilities Accounting and financial analysis abilities Management and administration abilities Industry knowledge International market perspective Leadership skills Decision-making skills Risk management skills
Bill Liu V V V V V V V
Maggie Chang V V V V V
Toshiyo Chen V V V V V V V
Sonia Wu V V V V V V
Willie Lin V V V V V V V
Will Wang V V V V V V
Jinn Wu V V V V V V V